Clinical Trial Update: Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the Esophagus [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating celecoxib, paclitaxel, and carboplatin for esophageal cancer has completed; the document provides no results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Celecoxib (Celecoxib)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Esophageal Cancer | Phase 2 | Status: COMPLETED